Businesses will have between 60 and 90 days to phase out their products. Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal decision issued Thursday.The Food and Drug Administration said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved, eliminating the need for copycat versions of the drugs that have become wildly popular with Americans trying to lose weight.The decision is a win for Lilly—which had been pressing the FDA to take the step for months—and is expected to impact how patients access the drugs, including how much they pay.Zepbound is FDA-approved to treat obesity and Mounjaro is approved for diabetes.
The Fda Has Ordered A Phaseout Of Knockoffs For These Blockbuster Weight-loss Drugs
Associated Press, Fast Company
Fri, 12/20/2024 - 1:15pm
Topics: specialty food drug administration eli lilly s zepbound americans lilly—which fda-approved ozempic—competing novo nordisk—remain fda s october lilly s zepbound mounjaro fda ro glp-1 blockbuster drugs versions pharmacies online decision shortage phase compounding companies ingredients patients off-brand obesity selling year telehealth supply demand diabetes days people businesses
BING NEWS:
- FDA says knockoff versions of weight loss drug must come off the market
Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal ...
12/19/2024 - 6:53 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more